Search

everythinglearnresearchcommunity

for

Search:↓

Most women with polycystic ovary syndrome (PCOS) have menstrual issues, infertility, acne, and excessive body hair, with the most common type being the non-androgenic phenotype.

Obesity is linked to higher metabolic syndrome and LH/FSH ratios, but no significant differences exist among PCOS phenotypes.

Keratin gene clusters in humans and marsupials are similarly organized.

Mouse hair follicle cells briefly grow during the early hair growth phase, showing that these cells are important for starting the hair cycle.

Id2 gene helps keep hair follicle stem cells inactive.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

150 kHz Electromagnetic Radiation seems to reduce the number and size of ovarian cysts in rats with PCOS, with minimal changes in developing follicles.

Most hair follicle stem cells do not protect their DNA by dividing it unevenly.

People with polycystic ovary syndrome have worse meibomian gland and ocular surface conditions.

New treatments for PCOS are improving fertility and managing symptoms better.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.

Suppressing ODC activity reduces tumor growth in hair follicles.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Enhanced stem cells from the placenta can help treat Graves' eye disease by stopping fat cell growth.

Nearly half of women with PCOS have metabolic syndrome, and lifestyle changes are crucial to prevent complications.

The error in figures didn't affect the study's results or conclusions.

Women with PCOS have higher levels of certain hormones compared to healthy women, and these levels vary with BMI, age, and treatment type.

The Oat mouse model shows mild retinal degeneration, useful for testing treatments.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Observers often disagree on ultrasound results for polycystic ovaries, needing better training for consistency.

MEF2C is crucial for normal hair cycle progression.